Budesonide and Gleevec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Gleevec (imatinib mesylate). Common drug interactions include burning sensation among females and cataract among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Gleevec. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

15 people who take Budesonide and Gleevec together, and have interactions are studied.

Budesonide and Gleevec drug interactions.

What are the common drug interactions of Budesonide and Gleevec, by gender? *:

female:

  1. Burning sensation
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Haemoglobin decreased
  4. Hypersensitivity
  5. Pain
  6. Rash generalised (rash on most of body parts)
  7. Vomiting
  8. Alopecia (absence of hair from areas of the body)
  9. Anaemia (lack of blood)
  10. Arthropathy

male:

  1. Cataract (clouding of the lens inside the eye)
  2. Photosensitivity reaction
  3. Eye irritation
  4. Muscle spasms (muscle contraction)
  5. Photophobia (extreme sensitivity to light)
  6. Vision blurred
  7. Visual impairment
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Back pain
  10. Blood amylase increased

What are the common drug interactions of Budesonide and Gleevec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood amylase increased
  2. Pancreatitis (inflammation of pancreas)

20-29:

n/a

30-39:

n/a

40-49:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Back pain
  3. Blood magnesium decreased
  4. Cholangitis (infection of the bile duct)
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Diarrhoea
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  9. Hepatic failure (liver failure)
  10. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)

50-59:

n/a

60+:

  1. Pneumonia
  2. Cellulitis (infection under the skin)
  3. Gene mutation identification test positive
  4. Haemoglobin decreased
  5. Muscle spasms (muscle contraction)
  6. Myalgia (muscle pain)
  7. Osteomyelitis (infection of bone)
  8. Reticulocyte count increased
  9. Weight increased
  10. Herpes zoster

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 26.67%
  2. Dyspnea (difficult or laboured breathing): 4 people, 26.67%
  3. High Blood Cholesterol: 4 people, 26.67%
  4. Gastrointestinal Stromal Tumor: 3 people, 20.00%
  5. Total Bile Acids Increased: 2 people, 13.33%
  6. Sleep Disorder: 2 people, 13.33%
  7. Blood Pressure Abnormal: 2 people, 13.33%
  8. Cough: 2 people, 13.33%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 13.33%
  10. Erection Problems: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Gleevec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Budesonide and Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on budesonide and imatinib mesylate (the active ingredients of Budesonide and Gleevec, respectively), and Budesonide and Gleevec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: